Divay Chandra1, Jason A Stamm2, Paul M Palevsky3, Joseph K Leader4, Carl R Fuhrman4, Yingze Zhang2, Jessica Bon1, Steven R Duncan2, Robert A Branch5, Joel Weissfeld6, David Gur4, Mark T Gladwin7, Frank C Sciurba8. 1. Emphysema COPD Research Center, University of Pittsburgh, Pittsburgh, PA. 2. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. 3. Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA. 4. Department of Radiology, University of Pittsburgh, Pittsburgh, PA. 5. Center for Clinical Pharmacology, University of Pittsburgh, Pittsburgh, PA. 6. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. 7. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA; Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA. 8. Emphysema COPD Research Center, University of Pittsburgh, Pittsburgh, PA. Electronic address: sciurbafc@upmc.edu.
Abstract
BACKGROUND: It has been reported that the prevalence of kidney dysfunction may be increased in patients exposed to tobacco with airflow obstruction. We hypothesized that kidney dysfunction would associate with emphysema rather than with airflow obstruction measured by the FEV₁. METHODS: Five hundred eight current and former smokers completed a chest CT scan, pulmonary function tests, medical questionnaires, and measurement of serum creatinine. Glomerular filtration rates (eGFRs) were estimated using the method of the Chronic Kidney Disease Epidemiology Collaboration. Quantitative determinants of emphysema and airway dimension were measured from multidetector chest CT scans. RESULTS: The mean age was 66 ± 7 years, and mean eGFR was 101 ± 22 mL/min/1.73 m². Univariate and multivariate analysis showed a significant association between radiographically measured emphysema and eGFR: Participants with 10% more emphysema had an eGFR that was lower by 4.4 mL/min/1.73 m² (P = .01), independent of airflow obstruction (FEV₁), age, sex, race, height, BMI, diabetes mellitus, hypertension, coronary artery disease, patient-reported dyspnea, pack-years of smoking, and current smoking. There was no association between eGFR and either FEV₁ or quantitative CT scan measures of airway dimension. CONCLUSIONS: More severe emphysema, rather than airflow obstruction, is associated with kidney dysfunction in tobacco smokers, independent of common risk factors for kidney disease. This finding adds to recent observations of associations between emphysema and comorbidities of COPD, including osteoporosis and lung cancer, which are independent of the traditional measure of reduced FEV₁. The mechanisms and clinical implications of kidney dysfunction in patients with emphysema need further investigation.
BACKGROUND: It has been reported that the prevalence of kidney dysfunction may be increased in patients exposed to tobacco with airflow obstruction. We hypothesized that kidney dysfunction would associate with emphysema rather than with airflow obstruction measured by the FEV₁. METHODS: Five hundred eight current and former smokers completed a chest CT scan, pulmonary function tests, medical questionnaires, and measurement of serum creatinine. Glomerular filtration rates (eGFRs) were estimated using the method of the Chronic Kidney Disease Epidemiology Collaboration. Quantitative determinants of emphysema and airway dimension were measured from multidetector chest CT scans. RESULTS: The mean age was 66 ± 7 years, and mean eGFR was 101 ± 22 mL/min/1.73 m². Univariate and multivariate analysis showed a significant association between radiographically measured emphysema and eGFR: Participants with 10% more emphysema had an eGFR that was lower by 4.4 mL/min/1.73 m² (P = .01), independent of airflow obstruction (FEV₁), age, sex, race, height, BMI, diabetes mellitus, hypertension, coronary artery disease, patient-reported dyspnea, pack-years of smoking, and current smoking. There was no association between eGFR and either FEV₁ or quantitative CT scan measures of airway dimension. CONCLUSIONS: More severe emphysema, rather than airflow obstruction, is associated with kidney dysfunction in tobacco smokers, independent of common risk factors for kidney disease. This finding adds to recent observations of associations between emphysema and comorbidities of COPD, including osteoporosis and lung cancer, which are independent of the traditional measure of reduced FEV₁. The mechanisms and clinical implications of kidney dysfunction in patients with emphysema need further investigation.
Authors: Joseph K Leader; Bin Zheng; Robert M Rogers; Frank C Sciurba; Andrew Perez; Brian E Chapman; Sanjay Patel; Carl R Fuhrman; David Gur Journal: Acad Radiol Date: 2003-11 Impact factor: 3.173
Authors: Jessica M Bon; Yingze Zhang; Steven R Duncan; Joseph M Pilewski; Diana Zaldonis; Adriana Zeevi; Kenneth R McCurry; Susan L Greenspan; Frank C Sciurba Journal: COPD Date: 2010-06 Impact factor: 2.409
Authors: MeiLan K Han; Alvar Agusti; Peter M Calverley; Bartolome R Celli; Gerard Criner; Jeffrey L Curtis; Leonardo M Fabbri; Jonathan G Goldin; Paul W Jones; William Macnee; Barry J Make; Klaus F Rabe; Stephen I Rennard; Frank C Sciurba; Edwin K Silverman; Jørgen Vestbo; George R Washko; Emiel F M Wouters; Fernando J Martinez Journal: Am J Respir Crit Care Med Date: 2010-06-03 Impact factor: 21.405
Authors: T Handa; S Nagai; S Ueda; K Chin; Y Ito; K Watanabe; K Tanizawa; M Tamaya; M Mishima; T Izumi Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2010-07 Impact factor: 0.670
Authors: Jessica Bon; Carl R Fuhrman; Joel L Weissfeld; Steven R Duncan; Robert A Branch; Chung-Chou H Chang; Yingze Zhang; Joseph K Leader; David Gur; Susan L Greenspan; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2010-10-08 Impact factor: 21.405
Authors: Ciro Casanova; Juan P de Torres; Juan Navarro; Armando Aguirre-Jaíme; Pablo Toledo; Elizabeth Cordoba; Rebeca Baz; Bartolomé R Celli Journal: Am J Respir Crit Care Med Date: 2010-06-17 Impact factor: 21.405
Authors: Francesca Polverino; Maria E Laucho-Contreras; Hans Petersen; Vanesa Bijol; Lynette M Sholl; Mary E Choi; Miguel Divo; Victor Pinto-Plata; Alfredo Chetta; Yohannes Tesfaigzi; Bartolomé R Celli; Caroline A Owen Journal: Am J Respir Crit Care Med Date: 2017-06-01 Impact factor: 21.405
Authors: Maria A Pabón; Edwin Patino; Divya Bhatia; Joselyn Rojas-Quintero; Kevin C Ma; Eli J Finkelsztein; Juan C Osorio; Faryal Malick; Francesca Polverino; Caroline A Owen; Stefan W Ryter; Augustine Mk Choi; Suzanne M Cloonan; Mary E Choi Journal: JCI Insight Date: 2018-09-20
Authors: Sankar D Navaneethan; Jesse D Schold; Haiquan Huang; Georges Nakhoul; Stacey E Jolly; Susana Arrigain; Raed A Dweik; Joseph V Nally Journal: Am J Nephrol Date: 2016-02-19 Impact factor: 3.754
Authors: Engi F Attia; Kathleen M Akgün; Cherry Wongtrakool; Matthew Bidwell Goetz; Maria C Rodriguez-Barradas; David Rimland; Sheldon T Brown; Guy W Soo Hoo; Joon Kim; Patty J Lee; Lynn M Schnapp; Amir Sharafkhaneh; Amy C Justice; Kristina Crothers Journal: Chest Date: 2014-12 Impact factor: 9.410
Authors: Divay Chandra; Aman Gupta; Patrick J Strollo; Carl R Fuhrman; Joseph K Leader; Jessica Bon; William A Slivka; Ali Hakim Shoushtari; Jennifer Avolio; Kevin E Kip; Steven Reis; Frank C Sciurba Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Divay Chandra; Aman Gupta; Gregory L Kinney; Carl R Fuhrman; Joseph K Leader; Alejandro A Diaz; Jessica Bon; R Graham Barr; George Washko; Matthew Budoff; John Hokanson; Frank C Sciurba Journal: Chest Date: 2021-05-08 Impact factor: 10.262
Authors: Bianca Harris; Ronald Klein; Michael Jerosch-Herold; Eric A Hoffman; Firas S Ahmed; David R Jacobs; Barbara E K Klein; Tien Y Wong; Joao A C Lima; Mary Frances Cotch; R Graham Barr Journal: PLoS One Date: 2012-12-20 Impact factor: 3.240